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Abstract 
Background: Risk of type 2 diabetes mellitus (T2DM) is increased in metabolically obese but normal-weight people. 
However, we have limited knowledge of how to prevent T2DM in normal-weight people. We aimed to evaluate the 
association between triglyceride glucose (TyG) index and incident T2DM among normal-weight people in rural China.
Methods: We included data from 5706 people with normal body mass index (BMI) (18.5–23.9 kg/m2) without base-
line T2DM in a rural Chinese cohort followed for a median of 6.0 years. A Cox proportional-hazard model was used to 
assess the risk of incident T2DM by quartiles of TyG index and difference in TyG index between follow-up and baseline 
(TyG-D), estimating hazard ratios (HRs) and 95% confidence intervals (CIs). A generalized additive plot was used to 
show the nonparametric smoothed exposure–response association between risk of T2DM and TyG index as a con-
tinuous variable. TyG was calculated as ln [fasting triglyceride level (mg/dl) × fasting plasma glucose level (mg/dl)/2].
Results: Risk of incident T2DM was increased with quartiles 2, 3 and 4 versus quartile 1 of TyG index (adjusted HR 
[aHR] 2.48 [95% CI 1.20–5.11], 3.77 [1.83–7.79], and 5.30 [2.21–12.71], Ptrend < 0.001 across quartiles of TyG index). Risk 
of incident T2DM was increased with quartile 4 versus quartile 1 of TyG-D (aHR 3.91 [2.22–6.87]). The results were 
consistent when analyses were restricted to participants without baseline metabolic syndrome and impaired fasting 
glucose level. The generalized additive plot showed cumulative increased risk of T2DM with increasing TyG index.
Conclusions: Risk of incident T2DM is increased with increasing TyG index among rural Chinese people, so the index 
might be an important indicator for identifying people at high risk of T2DM.
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Background
Diabetes is an important cause of mortality, morbidity, 
and health-system costs worldwide [1–3]. The number 
of diabetes deaths in the world nearly doubled between 
1990 and 2010 [4]. In 2015, the International Diabetes 
Federation estimated that 75% of people with diabetes 
live in low- and middle-income countries, particularly 
China, which has the largest number of people with dia-
betes in the world (109.6 million) [5]. Additionally, rural 
areas of China have lower economic development than 
urban areas and the people have poorer knowledge of 
type 2 diabetes mellitus (T2DM) control and prevention 
[6]. In this context, T2DM has been an important public 
health problem in rural China.
Adiposity is the most important modifiable risk factor 
for T2DM [7, 8]. Although body mass index (BMI) has 
been widely used as a reliable and simple measure of obe-
sity, many people with normal BMI, called “metabolically 
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obese but normal weight (MONW)”, are characterized 
by a cluster of metabolic risk factors, with significantly 
increased incidence of T2DM in many ethnic groups 
[9–11]. Moreover, normal-weight people may not moni-
tor their health indicators or take prevention measures 
for T2DM. Therefore, early identification of T2DM for 
normal-weight people is necessary. Particularly Chinese 
people, despite their lower absolute BMI, are more prone 
to visceral fat accumulation and insulin resistance (IR) 
than are Western populations [12, 13]. However, data are 
limited on the prevention of T2DM for normal-weight 
people in China.
Triglyceride glucose (TyG) index has been used as an 
inexpensive and reliable surrogate indicator to identify IR 
and T2DM [14–16]. The hyperinsulinemic-euglycemic 
clamp is considered the gold standard to define IR [16], 
but the technique is difficult to use in large epidemiology 
investigations because it is time-consuming, costly, and 
complex.
To our knowledge, the relationship between TyG and 
incident T2DM for normal-weight Chinese people has 
not been studied. Therefore, we designed a prospective 




This study was a population-based, prospective cohort 
study, and participants were selected by cluster rand-
omization from eligible candidates listed in the residen-
tial registration record from the rural district in Luoyang 
City, Henan Province, in the middle of China, for a base-
line examination during July to August of 2007 and July 
to August of 2008. First, Xin’an County was selected 
from Luoyang area, and then 2 towns were randomly 
selected from Xin’an County. Finally, a total of 64 vil-
lages were investigated from selected towns. Partici-
pants were excluded if they were (1) unable to answer the 
questionnaire; (2) unable to complete blood sampling or 
anthropometric or blood pressure measurements; and 
(3) known to have severe psychological disorders, Alzhei-
mer’s disease, dementia, AIDS or other infectious disease. 
Ultimately, we recruited 20,194 participants ≥18  years 
old. During July to August of 2013 and July to October 
of 2014, all participants were invited to undergo a follow-
up examination, and 17,265 participants (response rate 
85.5%) were re-investigated. The other characteristics 
for the study population have been previously published 
[17, 18]. For the present study, we examined data for 8003 
participants with normal weight (BMI 18.5–23.9  kg/m2 
according to the recommendations of Working Group on 
Obesity of China) [19]. After excluding 430 participants 
with T2DM at baseline (one with gestational diabetes 
also), 121 participants who died due to cancer, 64 partici-
pants who died due to cardiovascular disease, 132 partic-
ipants who died due to stroke, 163 participants who died 
due to accidents or other causes, and 1387 participants 
with missing lipid profile measures during follow-up, we 
had 5706 (3195 women) eligible for the current analyses.
Baseline examination and data collection
Baseline data were collected at local community clinics 
in the participants’ residential areas. Trained research 
staff administered a standard questionnaire to collect 
information on demographic characteristics, medical his-
tory, and lifestyle risk factors. Participants who had not 
smoked >100 cigarettes in their lifetime were considered 
never-smokers; the others were considered smokers [20]. 
Alcohol consumption was defined as drinking alcohol 
>12 times during the last year. Physical activity level was 
classified by the International Physical Activity Ques-
tionnaire scoring protocol [21]. Family history of diabe-
tes was defined as having at least one first-degree family 
member with diabetes.
Participants were asked to wear light clothes and be 
barefoot when measuring anthropometric indices. Body 
weight and height were measured to the nearest 0.1  kg 
and 0.1  cm, respectively, by trained investigators under 
standardized conditions following a standard protocol. 
BMI was calculated as weight in kilograms divided by 
the square of height in meters. With participants stand-
ing, waist circumference (WC) was measured midway 
between the lower edge of the costal arch and the upper 
edge of the iliac crest to the nearest 0.1 cm. Participants 
were measured twice, and the average was used. Waist-
to-height ratio (WHtR) was determined by WC (cm) 
divided by height (cm). Central obesity was defined by 
WC ≥90 cm for men and ≥80 cm for women or WHtR 
≥0.5 according to previous reports [22, 23]. Blood pres-
sure was measured by using an electronic sphygmoma-
nometer (Omron, HEM-770AFuzzy, Kyoto, Japan) after 
at least a 5-min rest, with participants in a seated posi-
tion, according to the American Heart Association stand-
ardized protocol [24]. The measurements were repeated 
three times with a 30-s interval, and the average was used 
for analysis.
Blood samples were obtained after an overnight fast of 
at least 8 h. Levels of fasting plasma glucose (FPG), tri-
glycerides (TG), total cholesterol (TC), and high-density 
lipoprotein cholesterol (HDL-C) were measured by using 
a HTACHI automatic clinical analyzer (Model 7060, 
Tokyo). Low-density lipoprotein cholesterol (LDL-C) 
level was calculated by the Friedewald formula [25]. TyG 
was calculated as ln[TG (mg/dl) × FPG (mg/dl)/2] [14]. 
The difference in TyG (TyG-D) was calculated as TyG 
value at the end of follow-up minus that at baseline.
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T2DM was defined as FPG ≥7.0 mmol/l and/or current 
treatment with anti-diabetes medication according to the 
China guideline for type 2 diabetes [26].
Follow‑up examination
Study participants or their proxies at their current 
address underwent in-depth interviews to ascertain dis-
ease status and vital information; hospital records and 
death certificates were obtained as well. Data collection 
at follow-up was the same as at baseline.
Statistical analysis
All continuous variables are described with median 
(interquartile range) because of skewed distribution. Cat-
egorical variables are presented as number (percentage). 
Study participants were classified by four TyG quartiles. 
The linear trend for baseline characteristics was tested 
by linear regression for continuous variables and logistic 
regression for categorical variables.
A Cox proportional-hazard regression model was used 
to estimate hazard ratios (HRs) and 95% confidence 
intervals (CIs) for incident T2DM by quartiles of TyG 
and TyG-D, with the lowest quartile as the reference. 
Besides the unadjusted model, 3 other models were fit-
ted: model 1, controlling for gender, age, family history 
of diabetes, and WC; model 2, additionally adjusted for 
education level, marital status, smoking, alcohol con-
sumption, and physical activity; model 3, adjusted for 
variables included in model 2 plus systolic blood pres-
sure (SBP), diastolic blood pressure (DBP) and TC, HDL-
C, and LDL-C levels (all of these factors related to FPG 
level). The linear trends across TyG and TyG-D quartiles 
were evaluated by a median value within each quartile as 
a continuous variable. The receiver operating character-
istic (ROC) curve and area under the ROC curve (AUC) 
were used to compare the ability of baseline TyG index, 
WC and WHtR to predict risk of T2DM at follow-up.
The cumulative incidence of T2DM and cumulative 
incidence curves by TyG quartile were examined by 
competing risk regression analysis. Generalized additive 
models were used to test for nonlinearity in the analy-
sis of risk of T2DM by TyG index with adjustment for 
potential confounding variables (gender, age, and family 
history of diabetes, WC, SBP, DBP, and TC, HDL-C and 
LDL-C levels).
Sensitivity analysis was conducted to assess the robust-
ness of the results by rerunning all the models exclud-
ing 899 participants with metabolic syndrome (Third 
Report of the National Cholesterol Education Program’s 
Adult Treatment Panel criteria components modified 
for WC cutoff according to World Health Organization 
Asia Pacific guidelines) [27] and 202 participants with 
impaired FPG level (FPG 6.1–7.0  mmol/l) [26, 28] at 
baseline. ROC analysis, competing risk regression analy-
sis and generalized additive model construction involved 
use of STATA v12.0 (STATA Corp, College Station, TX, 
USA) and other analyses involved SAS 9.1 (SAS Inst., 
Cary, NC, USA). Two-sided P < 0.05 was considered sta-
tistically significant.
Results
Baseline characteristics of study participants
Data were analyzed for 5706 normal-weight people 
(median age 51 years [interquartile range 40–60]). After 
34,246.00 person-years of follow-up, T2DM developed 
in 194 participants; the overall incidence of T2DM was 
5.66/1000 person-years. Age, BMI, WC, WHtR, SBP, 
and DBP were increased by quartiles of TyG index (all 
Ptrend < 0.001) (Table 1). Compared with participants with 
quartile 1 of TyG index, those with higher quartiles were 
more frequently older, women, with less education and 
less physically active. Marital status, smoking, alcohol 
consumption, and family history of diabetes were simi-
lar across TyG quartiles. FPG, TC, TG, and LDL-C lev-
els were increased and HDL-C level was decreased with 
increasing TyG quartile (all Ptrend < 0.001).
Risk of incident T2DM by quartiles of TyG and TyG‑D
With increasing TyG quartile, T2DM incidence increased 
substantially for normal-weight people, reaching an inci-
dence of 10.48/1000 person-years for quartile 4 of TyG 
index (Table  2). On competing risk analysis, the cumu-
lative risk of T2DM increased over time by baseline 
TyG quartile (Fig. 1) and remained significant even after 
adjustment for potential confounding factors (adjusted 
HR [aHR] [model 3] 2.48 [95% CI 1.20–5.11], 3.77 [1.83–
7.79], and 5.30 [2.21–12.71] for quartiles 2, 3 and 4 ver-
sus quartile 1 of TyG index) (Table 2). Moreover, risk of 
incident T2DM was increased with increasing TyG quar-
tile (Ptrend < 0.001). Risk of incident T2DM was increased 
with quartile 4 versus quartile 1 of TyG-D index (aHR 
3.91 [2.22–6.87]; model 3; Table 2) (Ptrend < 0.001).
Risk of incident T2DM was increased with per-unit 
increase in TyG index for both genders and all age 
groups (Fig. 2). With per-unit increase of baseline TyG 
value, the risk of T2DM increased twofold for men and 
fourfold for women (aHR 2.05 [95% CI 1.23–3.41] and 
4.04 [2.76–5.92], respectively; model 2). Risk of inci-
dent T2DM was increased with per-unit increase in 
TyG index for older men (aHR, 3.75 [1.75–8.05]) and 
women of all age groups. The risk with high TyG-D 
value was significantly associated with middle and older 
age groups for both men and women. These results 
were consistent with abdominal fat distribution for 
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different sex/age groups (Table  3). With WC criteria, 
the prevalence of central obesity was low for men of all 
age groups (1.62–1.91%), but with WHtR criteria, it was 
highest for older men (23.82%) as compared with young 
and middle-aged men. Regardless of the criteria used, 
women had the high prevalence of central obesity for all 
age groups.
ROC analyses for TyG, WC, and WHtR to predict the incident 
risk of T2DM
For men, the AUC for TyG, WC, and WHtR was 0.602 
(0.583–0.622), 0.596 (0.576–0.615), and 0.608 (0.588–
0.627), respectively (Fig. 3). The AUC for TyG index, WC, 
and WHtR was larger for women than men: 0.733 (0.717–
0.748), 0.630 (0.613–0.647), and 0.659 (0.643–0.676), 
respectively, with significant differences between AUCs for 
TyG index and WC (P = 0.005) and TyG index and WHtR 
(P = 0.04). The best TyG value for diagnosis of T2DM was 
8.64 (sensitivity 0.522, specificity 0.642) for men and 8.76 
(sensitivity 0.650, specificity 0.702) for women.
Generalized additive plot for TyG and T2DM risk
Figure  4 shows the nonparametric smoothed exposure–
response relationship between TyG index and T2DM risk 
(TyG index as a continuous variable). The function for 
TyG index showed significant nonlinearity (P < 0.001) with 
T2DM risk, and the slope increased with increasing TyG 
index.
Results of sensitivity analysis
The main results of the current study were consistent 
when analyses were restricted to participants without 
metabolic syndrome and impaired FPG level at baseline 
(Table 4). After 27,801.75 person-years of follow-up, the 
T2DM incidence was 3.45/1000 person-years (96 cases) 
(data not shown). Risk of T2DM was increased by 4.29-
fold (95% CI 1.72–10.67) and 5.88-fold (95% CI 2.06–
16.76) with quartiles 3 and 4 versus quartile 1 of TyG, 
respectively (model 3). A generalized additive model plot 
showed that TyG index had significant nonlinearity with 
T2DM risk (P  =  0.25) (Fig.  5), but the association was 
Table 1 Baseline characteristics of study participants stratified by quartiles of triglyceride glucose (TyG) index
 Significant P values (P < 0.05) are in italics
Data are median (interquartile range) or no. (%)
BMI body mass index, WC waist circumference, WHtR waist-to-height ratio, FPG fasting plasma glucose, SBP systolic blood pressure, DBP diastolic blood pressure, TC 
total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TyG triglyceride glucose
a Partial data deletion
Variables TyG index quartiles Ptrend
Quartile 1 (<8.16) 
n = 1423
Quartile 2 (8.16–8.47) 
n = 1422
Quartile 3 (8.48–8.81) 
n = 1429
Quartile 4 (≥8.82) 
n = 1424
Age (years) 44.00 (36.00–56.00) 51.00 (40.00–60.00) 52.00 (43.00–61.00) 54.00 (44.00–62.00) <0.001
Men 618 (43.43) 679 (47.75) 638 (44.65) 571 (40.10) 0.03
High school or above 156 (10.96) 180 (12.66) 140 (9.80) 121 (8.50) <0.01
Married/cohabiting 1274 (89.53) 1294 (91.06) 1306 (91.39) 1303 (91.50) 0.07
Smoking 436 (30.64) 495 (34.81) 456 (31.91) 411 (28.86) 0.14
Drinking 160 (11.24) 166 (11.67) 179 (12.53) 161 (11.31) 0.78
Physical activity
 Low 793 (55.73) 777 (54.64) 755 (52.83) 692 (48.60) <0.001
 Middle 282 (19.82) 279 (19.62) 290 (20.29) 321 (22.54)
 High 348 (24.46) 366 (25.74) 384 (26.87) 411 (28.86)
Family history of diabetesa 60 (5.24) 62 (5.36) 56 (4.83) 70 (6.03) 0.54
BMI (kg/m2) 21.53 (20.39–22.60) 21.57 (20.32–22.73) 21.94 (20.69–23.01) 22.35 (21.20–23.24) <0.001
WC (cm) 73.75 (70.25–78.00) 74.50 (70.75–78.75) 76.03 (71.93–80.50) 78.25 (74.10–82.15) <0.001
WHtR 0.46 (0.44–0.49) 0.47 (0.44–0.49) 0.48 (0.45–0.51) 0.49 (0.47–0.52) <0.001
FPG (mmol/l) 5.00 (4.71–5.31) 5.18 (4.86–5.48) 5.27 (4.98–5.62) 5.43 (5.14–5.81) <0.001
SBP (mmHg) 113.67 (105.33–126.00) 118.00 (108.00–130.67) 119.00 (109.33–131.67) 123.00 (112.33–136.67) <0.001
DBP (mmHg) 71.67 (66.33–78.33) 74.00 (68.00–81.00) 74.67 (69.00–81.67) 77.00 (70.00–84.00) <0.001
TC (mmol/l) 3.79 (3.38–4.27) 4.10 (3.65–4.64) 4.37 (3.85–4.96) 4.72 (4.09–5.28) <0.001
TG (mmol/l) 0.69 (0.59–0.78) 1.01 (0.92–1.10) 1.35 (1.23–1.48) 2.03 (1.78–2.56) <0.001
HDL-C (mmol/l) 1.25 (1.10–1.44) 1.21 (1.04–1.39) 1.17 (1.02–1.36) 1.10 (0.95–1.25) <0.001
LDL-C (mmol/l) 2.20 (1.90–2.60) 2.40 (2.00–2.90) 2.60 (2.10–3.10) 2.60 (2.10–3.10) <0.001
TyG index 7.93 (7.77–8.06) 8.33 (8.25–8.41) 8.64 (8.57–8.73) 9.08 (8.94–9.31) <0.001
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almost linear after excluding participants with metabolic 
syndrome and impaired FPG level at baseline.
Discussion
This population-based prospective cohort study sug-
gests a cumulative increased risk of incident T2DM 
with increasing TyG index in rural Chinese people with 
normal weight. These findings appeared to extend the 
risk of T2DM to normal-weight participants without 
baseline metabolic syndrome and impaired FPG level. 
To our knowledge, this study is the first to demonstrate 
a significant association between TyG index, a biomarker 
of IR, and incident T2DM in rural normal-weight Chi-
nese people. This association was particularly evident for 
women of all age groups and for older men, which may 
due to the abdominal fat distribution for different sex/age 
groups in our population (Table 3). In addition, women 
tend to have higher hepatocellular lipids, both fasting and 
after glucose and lipid loading as compared with men 
[29, 30]. As people age, visceral adiposity tissue is signifi-
cantly increased for both genders, which can increase the 
risk of T2DM [29]. As well, risk of incident T2DM was 
increased with high TyG value at follow-up for normal-
weight people, which agrees with results from Korea [31].
Many observational studies demonstrated that more 
than 30% of normal-weight people have metabolic abnor-
malities (MONW-like phenotype), including abdominal 
fat accumulation and IR [11, 32, 33]. Prospective cohort 
studies have demonstrated increased risk of T2DM in 
people with MONW in different ethnic groups [11, 33, 
34]. Data from the Whitehall II study showed that the 
incidence of T2DM for MONW people was 12.46/1000 
Table 2 Risk of incident type 2 diabetes mellitus (T2DM) by quartiles of TyG and TyG-D
Data are hazard ratios (HRs) and 95% confidence intervals (95% CIs)
TyG triglyceride glucose index, TyG-D difference in TyG value at the end of follow-up minus that at baseline
a Per 1000 person-years
b Adjusted for gender, age, family history of diabetes and WC
c Adjusted for variables in b as well as education level, marital status, smoking, alcohol consumption and physical activity
d Adjusted for variables in c as well as SBP, DBP and TC, HDL-C and LDL-C levels
Quartile 1 Quartile 2 Quartile 3 Quartile 4 Ptrend
TyG
 Range <8.16 8.16 to 8.47 8.48 to 8.81 ≥8.82
 No. of cases 18 35 52 88
 No. of person-years 8740.50 8526.83 8529.25 8399.50
 Incidence ratea 2.06 4.10 6.10 10.48 <0.001
 Unadjusted model 1 (ref ) 2.36 (1.33–4.16) 3.58 (2.09–6.12) 6.30 (3.78–10.50) <0.001
 Multivariable adjusted model 1b 1 (ref ) 2.38 (1.17–4.85) 3.71 (1.89–7.29) 5.54 (2.87–10.71) <0.001
 Multivariable adjusted model 2c 1 (ref ) 2.49 (1.22–5.08) 3.89 (1.98–7.65) 5.69 (2.94–11.01) <0.001
 Multivariable adjusted model 3d 1 (ref ) 2.48 (1.20–5.11) 3.77 (1.83–7.79) 5.30 (2.21–12.71) <0.001
TyG-D
 Range <−0.27 −0.27 to 0 0.01 to 0.31 ≥0.32
 No. of cases 41 39 30 83
 No. of person-years 8520.00 9747.08 7373.00 8556.00
 Incidence ratea 4.81 4.00 4.07 9.70 <0.001
 Unadjusted model 1 (ref ) 0.95 (0.58–1.55) 1.15 (0.68–1.93) 2.19 (1.41–3.39) <0.001
 Multivariable adjusted model 1b 1 (ref ) 0.92 (0.52–1.63) 1.09 (0.59–2.03) 2.51 (1.50–4.19) <0.001
 Multivariable adjusted model 2c 1 (ref ) 0.92 (0.52–1.64) 1.10 (0.59–2.05) 2.52 (1.51–4.22) <0.001
 Multivariable adjusted model 3d 1 (ref ) 1.14 (0.63–2.09) 1.54 (0.80–2.99) 3.91 (2.22–6.87) <0.001
Fig. 1 Cumulative incidence of type 2 diabetes mellitus (T2DM) by 
quartiles of triglyceride glucose (TyG) index. Gray dash line quartile 
1; gray solid line quartile 2; black dash line quartile 3; black solid line 
quartile 4
Page 6 of 11Zhang et al. Cardiovasc Diabetol  (2017) 16:30 
person-years, and the risk of incident T2DM was more 
than threefold increased as compared with metabolically 
healthy and normal weight people [11]. Similar results 
were observed in an Asian population [33]. However, 
measures to prevent T2DM in normal-weight people are 
lacking. Our results provide evidence that the TyG index 
can be an important indicator for predicting T2DM 
among normal-weight people.
Decreased β-cell function and IR are considered cen-
tral events in the development of T2DM [35]. Islets have 
intrinsically low antioxidant enzyme defenses; elevated 
glucose concentrations increasing levels of reactive oxy-
gen species in β cells have toxic effects on β cells, fur-
ther leading to IR and T2DM [36]. Under conditions 
such as lipodystrophy, the lipolysis is enhanced, and 
prolonged fatty-acid exposure in β cells can decrease 
glucose-induced insulin secretion, impair insulin gene 
expression, and increase cell death [37–39]. As well, TG 
overload in islets interferes with glucose metabolism and 
impairs the function of β cells [40]. When both fatty acids 
Fig. 2 Association of T2DM and TyG index or TyG-D by sex and/or age groups. Data are hazard ratios (HRs) and 95% confidence limits (95% CLs). 
T2DM type 2 diabetes mellitus, TyG index triglyceride glucose index, TyG-D difference in TyG value at the end of follow-up minus that at baseline. 
Asterisk adjusted for gender, age, education level, marital status, smoking, alcohol consumption, physical activity, family history of diabetes and waist 
circumference (WC)
Table 3 The prevalence of central obesity at baseline based on WC and WHtR criteria by age and gender
WC waist circumference, WHtR waist-to-height ratio
N Defined by WC Defined by WHtR
No. of individuals Prevalence (%) No. of individuals Prevalence (%)
Men
 18–39 450 8 1.78 40 8.89
 40–59 1259 24 1.91 203 16.14
 ≥60 802 13 1.62 191 23.82
Women
 18–39 846 100 11.82 129 15.25
 40–59 1622 307 18.49 558 34.42
 ≥60 727 241 33.20 424 58.40
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and glucose are elevated, the accumulation of metabo-
lites derived from fatty-acid esterification impairs β-cell 
function [36]. Changes in TG and HDL-C have a unidi-
rectional relationship with peripheral IR, which provides 
evidence for the early prevention of IR by improving dys-
lipidemia [41]. Studies of diabetes patients added that the 
capacity for insulin secretion and IR are closely affected 
by TG and FPG levels [42–44], which was also confirmed 
in an intervention study [45]. After appropriate treat-
ment of high TG and high FPG level by n-3 fatty acids in 
patients with impaired glucose metabolism, the ability of 
insulin secretion was improved [45].
Visceral adipose tissue is associated with increased 
cytokine production and IR [46]. Epidemiology studies 
have found BMI inadequate to define obesity; it cannot 
adequately discriminate between fat mass and lean tis-
sues nor identify regional body fat distribution [47–49]. A 
population-based cross-sectional study of Chinese people 
showed T2DM significantly associated with central obe-
sity among adults with normal BMI [47]. Another study 
of a Japanese population demonstrated risk of prediabe-
tes with upper-normal WC for people with normal WC 
and BMI after adjusting for BMI [48]. This situation may 
explain why some people with normal BMI show signifi-
cantly increased risk of T2DM. Another explanation may 
be inherited genetic factors. The genetic variation near 
insulin receptor substrate 1 (IRS1) is associated with low 
body fat but also impaired metabolic profile, including 
decreased subcutaneous-to-visceral fat ratio, increased 
insulin resistance, dyslipidemia, risk of diabetes and coro-
nary artery disease, and decreased adiponectin level [49].
TyG index, a biomarker related to IR [50, 51], can be 
used in clinical practice because measuring TG and 
Fig. 3 ROC curves for TyG, WC, and WHtR for predicting T2DM among men (a), and women (b). ROC receiver operating characteristic, TyG index 
triglyceride glucose index, WC waist circumference, WHtR waist-to-height ratio, T2DM type 2 diabetes mellitus. Solid black line TyG; solid gray line,WC; 
dotted black line WHtR. Asterisk compared with TyG
Fig. 4 Generalized additive model plot for risk of T2DM and TyG 
index. Adjusted for gender, age, family history of diabetes, waist cir-
cumference (WC), systolic blood pressure (SBP), diastolic blood pres-
sure (DBP), total cholesterol (TC), high-density lipoprotein cholesterol 
(HDL-C) and low-density lipoprotein cholesterol (LDL-C). T2DM type 2 
diabetes mellitus, TyG index triglyceride glucose index 
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glucose is inexpensive and routine. As compared with 
the hyperinsulinemic-euglycemic clamp, the TyG index 
showed high sensitivity (96.5%) and specificity (85.0%) 
for diagnosis of insulin resistance in Mexican people 
[52]. The validation study was conducted in a Brazilian 
population, and TyG index performed better than home-
ostatic model assessment for measuring IR in clinical 
practice [16]. In a 4-year retrospective longitudinal study 
of Korean people, high baseline TyG index was related 
to T2DM development regardless of obesity status [53]. 
Therefore, the TyG index may be clinically important 
for preventing T2DM. However, compared with other 
routine biomarkers, the ability of TyG to identify IR or 
T2DM was controversial in different ethnic groups. TyG 
index did not improve diabetes prediction as compared 
with FPG, 1-h plasma glucose, and 2-h plasma glucose 
in an Iranian population [54]. However, in a large Euro-
pean population, TyG index was a better predictor than 
FPG or TG level of T2DM development in normoglyce-
mic people [15]. Compared with obesity-related mark-
ers (BMI and WC) and single lipid markers (TC, TG, 
HDL-C, and LDL-C), TyG index had a larger AUC for 
identifying IR and diabetes but lower than the markers 
combining TyG and obesity (TyG-WC and TyG-BMI) for 
Chinese people [55, 56]. In the present study, the ability 
of TyG index to predict incident T2DM was similar to 
WC and WHtR for men but better than WC or WHtR 
for women.
Table 4 Risk of incident T2DM for participants without metabolic syndrome and impaired FPG level at baseline
Data are hazard ratios (HRs) and 95% confidence intervals (95% CIs)
a Per 1000 person-years
b Adjusted for gender, age, family history of diabetes and WC
c Adjusted for variables in b as well as education level, marital status, smoking, alcohol consumption and physical activity
d Adjusted for variables in c as well as SBP, DBP and TC, HDL-C and LDL-C levels
Quartile 1 Quartile 2 Quartile 3 Quartile 4 Ptrend
TyG
 Range <8.09 8.09 to 8.39 8.40 to 8.68 ≥8.69
 No. of cases 12 15 32 37
 No. of person-years 7078.67 6945.58 6914.00 6832.42
 Incidence ratea 1.70 2.16 4.63 5.42 <0.001
 Unadjusted model 1 (ref ) 1.42 (0.67–3.04) 3.10 (1.60–6.03) 3.75 (1.95–7.23) <0.001
 Multivariable adjusted model 1b 1 (ref ) 1.19 (0.43–3.30) 3.50 (1.50–8.16) 4.36 (1.89–10.05) <0.001
 Multivariable adjusted model 2c 1 (ref ) 1.25 (0.45–3.46) 3.68 (1.57–8.60) 4.54 (1.97–10.47) <0.001
 Multivariable adjusted model 3d 1 (ref ) 1.34 (0.48–3.76) 4.29 (1.72–10.67) 5.88 (2.06–16.76) <0.001
TyG-D
 Range <−0.23 −0.23 to 0 0.01 to 0.35 ≥0.35
 No. of cases 17 14 20 45
 No. of person-years 6912.75 7101.50 6797.33 6959.08
 Incidence ratea 2.46 1.97 2.94 6.47 <0.001
 Unadjusted model 1 (ref ) 0.78 (0.37–1.64) 1.37 (0.69–2.70) 2.40 (1.31–4.39) <0.001
 Multivariable adjusted model 1b 1 (ref ) 0.78 (0.33–1.84) 0.97 (0.41–2.28) 2.86 (1.40–5.84) <0.001
 Multivariable adjusted model 2c 1 (ref ) 0.80 (0.34–1.90) 0.98 (0.42–2.32) 2.90 (1.42–5.93) <0.001
 Multivariable adjusted model 3d 1 (ref ) 0.99 (0.42–2.36) 1.43 (0.60–3.43) 4.56 (2.14–9.70) <0.001
Fig. 5 Generalized additive model plot for T2DM and TyG with 
participants without baseline IFG and MetS. IFG impaired fasting 
glucose, MetS metabolic syndrome, T2DM type 2 diabetes mellitus, 
TyG index triglyceride glucose index. Adjusted for gender, age, family 
history of diabetes, waist circumference (WC), systolic blood pressure 
(SBP), diastolic blood pressure (DBP), total cholesterol (TC), high-
density lipoprotein cholesterol (HDL-C) and low-density lipoprotein 
cholesterol (LDL-C)
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For normal-weight people, only one study conducted in 
rural Korea reported that TyG index was useful for pre-
dicting the incidence of T2DM in both men and women 
[33]. Hence, the index needs to be validated to iden-
tify T2DM in normal-weight people in different ethnic 
groups. In our rural Chinese normal-weight population, 
risk of incident T2DM increased with increasing TyG 
value, and the association was almost linear for people 
with baseline normal FPG level and metabolic health.
The strengths of the study include its prospective design, 
large community-based sample of men and women across 
a broad age spectrum, high rates of participation, standard-
ized high-quality clinical and laboratory procedures, and 
adjustment for a large number of potential confounders. We 
also conducted a sensitivity analysis to assess the robustness 
of the association between TyG index and incident T2DM 
risk by rerunning all the models excluding participants with 
metabolic syndrome and impaired FPG level at baseline.
However, the study has several limitations. First, we did 
not use 2-h oral glucose tolerance test and glycated hae-
moglobin (HbA1c) for diagnosing T2DM, so we may have 
underestimated the incidence of T2DM. As well, most of 
our participants were not clear about whether they used 
lipid-lowering medications, so we did not include this 
variable in the analysis. Finally, because all participants 
were rural Chinese people, the applicability and utility of 
TyG index for predicting T2DM in normal-weight people 
should be confirmed in other ethnic populations.
Conclusions
Our study suggests an increased risk of T2DM with 
increasing TyG index for normal-weight people in a Chi-
nese rural cohort, particularly women. TyG may be use-
ful for predicting T2DM among normal-weight people.
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